Showing results (121-130 of 141) with videos related to
Sort By:
Pageof 15
Internal Medicine Journal|August 18, 2016
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participationT Luckett, J Phillips, N Lintzeris, et al.Plos One|June 5, 2013
Eliciting renal failure in mosquitoes with a small-molecule inhibitor of inward-rectifying potassium channelsRene Raphemot, Matthew F Rouhier, Corey R Hopkins, et al.Oncogene|February 15, 2001
Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transferR P Kruzelock, B D Cuevas, J R Wiener, et al.Bioorganic & Medicinal Chemistry|January 17, 2015
Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motifKevin J Frankowski, Stephen R Slauson, Kimberly M Lovell, et al.Bioorganic & Medicinal Chemistry|April 3, 2012
Semisynthetic neoclerodanes as kappa opioid receptor probesKimberly M Lovell, Tamara Vasiljevik, Juan J Araya, et al.Science (New York, N.Y.)|June 8, 1990
Explosive deep water basalt in the sumisu backarc riftJ Gill, P Torssander, H Lapierre, et al.International Journal of Clinical and Health Psychology : IJCHP|November 30, 2018
Disorders specifically associated with stress: A case-controlled field study for ICD-11 mental and behavioural disordersJared W Keeley, Geoffrey M Reed, Michael C Roberts, et al.The American Journal on Addictions|February 19, 2013
Witnessed versus unwitnessed random urine tests in the treatment of opioid dependenceAshok Mallya, Amanda L Purnell, Dragan M Svrakic, et al.Plos One|November 7, 2014
Discovery and characterization of a potent and selective inhibitor of Aedes aegypti inward rectifier potassium channelsRene Raphemot, Matthew F Rouhier, Daniel R Swale, et al.Bioorganic & Medicinal Chemistry Letters|June 4, 2013
N-Acyl-N'-arylpiperazines as negative allosteric modulators of mGlu1: identification of VU0469650, a potent and selective tool compound with CNS exposure in ratsKimberly M Lovell, Andrew S Felts, Alice L Rodriguez, et al.Pageof 15